Editas Medicine

Read more
James C. Mullen's photo - Chairman & CEO of Editas Medicine

Chairman & CEO

James C. Mullen

CEO Approval Rating

85/100

Founded:

2013

Status:

PublicIndependent CompanyNASDAQEDIT

EDITAS MEDICINE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Arbor Biotechnologies is one of Editas Medicine's top rivals. Arbor Biotechnologies's headquarters is in Cambridge, Massachusetts, and was founded in 2016. Like Editas Medicine, Arbor Biotechnologies also competes in the Biotechnology industry. Arbor Biotechnologies generates 6.17% of Editas Medicine's revenue.

Caribou has been one of Editas Medicine's top competitors. Caribou was founded in 2011 in Berkeley, California. Like Editas Medicine, Caribou also operates in the Biotechnology field. Caribou generates $96.2M less revenue than Editas Medicine.

CRISPR is one of Editas Medicine's top competitors. CRISPR was founded in Zug, Zug} in 2013. Like Editas Medicine, CRISPR also competes in the Biotechnology sector. Compared to Editas Medicine, CRISPR generates $96.1M less revenue.

Editas Medicine Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$97.2M

Editas Medicine's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 355.5M. Over the last four quarters, Editas Medicine's revenue has decreased by 39.5%. Specifically, in Q1 2021's revenue was $6.5M; in Q4 2020, it was $17.1M; in Q3 2020, it was $62.8M; in Q2 2020, Editas Medicine's revenue was $10.7M.

Editas Medicine Acquisitions

No recent acquisitions found related to Editas Medicine

Editas Medicine Funding History

Since Editas Medicine was founded in 2013, it has participated in 4 rounds of funding. In total Editas Medicine has raised $473.0M. Editas Medicine's last funding round was on Jun 2020 for a total of $215.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jun 2020
$215.6M
-
IPO
Feb 2016
$94.4M
-
Series B
Aug 2015
$120M
Series A
Nov 2013
$43M

Since Editas Medicine was founded in 2013, it has participated in 4 rounds of funding. In total Editas Medicine has raised $473.0M. Editas Medicine's last funding round was on Jun 2020 for a total of $215.6M

Editas Medicine Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.
$87M
Feb 08, 2018
Series A
Feb 05, 2020

These are all the companies that Editas Medicine has invested in. Editas Medicine's latest investment was Beam in Feb 08,. Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.

Editas Medicine News

Editas Medicine Press Releases

Social Media

Editas Medicine Headquarters

11 Hurley Street

Cambridge, Massachusetts02141

617-401-9000

Driving Directions »

Trending Companies

Editas Medicine Summary

ABOUT

Overview

Editas Medicine is a biotechnology company that develops and commercializes gene-edited therapeutics for the treatment of serious diseases. Editas Medicine was founded in 2013. Editas Medicine's headquarters is located in Cambridge, Massachusetts, USA...

CEO

Editas Medicine's Chairman & CEO, James C. Mullen, currently has an approval rating of 85%. Editas Medicine's primary competitors are Arbor Biotechnologies, Caribou & CRISPR.

Frequently Asked Questions about Editas Medicine

  1. When was Editas Medicine founded?

    Editas Medicine was founded in 2013
  2. Who is Editas Medicine's CEO?

    Editas Medicine's CEO is James C. Mullen
  3. How much revenue does Editas Medicine generate?

    Editas Medicine generates $97.2M in revenue
  4. How much funding does Editas Medicine have?

    Editas Medicine has historically raised $473M in funding
  5. Where is Editas Medicine's headquarters?

    Editas Medicine's headquarters is in Cambridge Massachusetts, USA
  1. How many employees does Editas Medicine have?

    Editas Medicine has 133 employees
  2. What sector does Editas Medicine operate in?

    Editas Medicine is in Biotechnology
  3. Who are Editas Medicine's competitors?

    Editas Medicine's top competitors are Arbor Biotechnologies, Caribou, CRISPR
  4. Who has Editas Medicine invested in?

    Editas Medicine's has invested in companies such as Beam